 Shares of small-cap penny stock Bluejay Diagnostics, Inc. NASDAQ: BJDX are trading higher after the company announced that the FDA has agreed to consider its plan to pursue a De Novo submission for the Symphony IL-6 Test. Neil Dey, Chief Executive Officer, said This confirms our. 